HTA15 An Assessment of the Evidence Published Post-HTA for Selected HER2-Positive, Early Breast Cancer Medicines, to Address Potential HTA-Body Uncertainties
Abstract
Authors
E Anastasaki T Harding J Ryan A Seddik K Dunton M Becce CJ Crossman-Barnes